Dr. Nahid is Professor of Medicine, Director of Clinical Trials Operations in the UCSF Office of Research, Director of the UCSF CTSA Trials Innovation Network Hub, and Director of the UCSF Center for Tuberculosis. With over two decades of experience in global health research, he specializes in clinical trials and translational research focusing on TB and HIV/TB. In 2009, he co-founded the Vietnam National TB Program/UCSF Research Collaboration Unit, launching partnerships with the Vietnam National Lung Hospital, Hanoi Lung Hospital, and Pham Ngoc Thach Hospital in support of equitable international research activities in global health.

Seda is a molecular biologist with postgraduate training in molecular life sciences (MSc, PhD) and global health (MSc) from the University of Geneva, Switzerland. She worked at FIND, the Global Alliance for Diagnostics, in various capacities from 2015 to 2021. She joined the Denkinger group in February 2021 as the technology lead for the NIH-funded R2D2 TB Network. She has experience and knowledge in infectious disease diagnostics, clinical research, and global health issues, especially in the areas of tuberculosis and malaria. 

Sonal joined the R2D2 TB Network in September 2023 as a Technology Officer. She has a masters degree in Bioengineering and has previously worked as a scientist at molecular diagnostic start-ups in the US. Her background is in molecular biology and assay development, and she is passionate about bringing novel TB diagnostics to market.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Peter joined the R2D2 network in 2021 as a consultant. His professional career both in Public Health as well as in the Diagnostics Industry provides him with a rich background in understanding 'both sides of the coin'. His experience in the field of TB diagnostics stems from his former role at FIND Diagnostics as well as from his global responsibilities for TB at Roche Diagnostics and bioMérieux. As a retired IVD expert he continues to provide advice to a number of global players, start-up companies and service providers.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Chris joined the R2D2 TB Network in March 2021 as a Technology Scouting Consultant. As a digital health specialist he has helped numerous organisations to implement innovative solutions and to harness the power of health data to save lives and eradicate disease. Chris is CEO of Connected Diagnostics Ltd, a specialist consultancy helping manufacturers of medical diagnostics to implement connectivity.